v3.24.0.1
Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss), Net
Accumulated Deficit
Parent
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2020   1,792,140,000          
Beginning balance at Dec. 31, 2020 $ 1,522,550 $ 1,792 $ 6,488,857 $ (2,745) $ (4,965,354)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from the exercise of stock options (in shares)   178,849,000          
Issuance of common stock from the exercise of stock options 507,455 $ 178 507,277        
Issuance of common stock upon vesting of restricted stock units ("RSUs") (in shares)   50,350,000          
Issuance of common stock upon vesting of restricted stock units (“RSUs”) 0 $ 50 (50)        
Issuance of common stock upon vesting of growth units (shares)   1,471,000          
Issuance of common stock upon vesting of growth units 0 $ 1 (1)        
Issuance of common stock upon net exercise of common stock warrants and other (in shares)   4,664,000          
Issuance of common stock upon net exercise of common stock warrants and other 1,712 $ 6 1,706        
Stock-based compensation 779,296   779,296        
Other comprehensive income (loss) 396     396      
Net income (loss) (520,379)       (520,379)    
Ending balance (in shares) at Dec. 31, 2021   2,027,474,000          
Ending balance at Dec. 31, 2021 2,291,030 $ 2,027 7,777,085 (2,349) (5,485,733) $ 2,291,030 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from the exercise of stock options (in shares)   19,660,000          
Issuance of common stock from the exercise of stock options 86,088 $ 20 86,068     86,088  
Issuance of common stock upon vesting of restricted stock units ("RSUs") (in shares)   51,941,000          
Issuance of common stock upon vesting of restricted stock units (“RSUs”) 0 $ 52 (52)        
Stock-based compensation 564,897   564,897     564,897  
Other comprehensive income (loss) (2,984)     (2,984)   (2,984)  
Noncontrolling interests 74,500           74,500
Net income (loss) $ (371,094)       (373,705) (373,705) 2,611
Ending balance (in shares) at Dec. 31, 2022 2,099,075,000 2,099,075,000          
Ending balance at Dec. 31, 2022 $ 2,642,437 $ 2,099 8,427,998 (5,333) (5,859,438) 2,565,326 77,111
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from the exercise of stock options (in shares) 46,079,000 46,079,000          
Issuance of common stock from the exercise of stock options $ 218,238 $ 46 218,192     218,238  
Issuance of common stock upon vesting of restricted stock units ("RSUs") (in shares)   54,974,000          
Issuance of common stock upon vesting of restricted stock units (“RSUs”) 0 $ 55 (55)        
Stock-based compensation 476,038   476,038     476,038  
Other comprehensive income (loss) 6,134     6,134   6,134  
Other, net 743           743
Net income (loss) $ 217,375       209,825 209,825 7,550
Ending balance (in shares) at Dec. 31, 2023 2,200,128,000 2,200,128,000          
Ending balance at Dec. 31, 2023 $ 3,560,965 $ 2,200 $ 9,122,173 $ 801 $ (5,649,613) $ 3,475,561 $ 85,404